These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21351459)

  • 1. [The crystalline polymorph control and selection of gabapentin with polymer heteronuclei].
    Yang L; Ru ML; Lang MD
    Yao Xue Xue Bao; 2010 Jan; 45(1):109-13. PubMed ID: 21351459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive steps of polymorphic transformation of gabapentin polymorphs studied by hot-stage FTIR microspectroscopy.
    Hsu CH; Ke WT; Lin SY
    J Pharm Pharm Sci; 2010; 13(1):67-77. PubMed ID: 20456832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
    Tinmanee R; Larsen SC; Morris KR; Kirsch LE
    J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of a new polymorphic form of gabapentin monohydrate and the e and z isomers of 4-tertiarybutylgabapentin.
    Vasudev PG; Aravinda S; Ananda K; Veena SD; Nagarajan K; Shamala N; Balaram P
    Chem Biol Drug Des; 2009 Jan; 73(1):83-96. PubMed ID: 19016796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphs of gabapentin.
    Reece HA; Levendis DC
    Acta Crystallogr C; 2008 Mar; 64(Pt 3):o105-8. PubMed ID: 18322329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state transformation of different gabapentin polymorphs upon milling and co-milling.
    Lin SY; Hsu CH; Ke WT
    Int J Pharm; 2010 Aug; 396(1-2):83-90. PubMed ID: 20561572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stabilizing effect of moisture on the solid-state degradation of gabapentin.
    Zong Z; Desai SD; Kaushal AM; Barich DH; Huang HS; Munson EJ; Suryanarayanan R; Kirsch LE
    AAPS PharmSciTech; 2011 Sep; 12(3):924-31. PubMed ID: 21744168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C9 helices and ribbons in gamma-peptides: crystal structures of gabapentin oligomers.
    Vasudev PG; Shamala N; Ananda K; Balaram P
    Angew Chem Int Ed Engl; 2005 Aug; 44(31):4972-5. PubMed ID: 16003813
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
    Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
    Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers.
    Tulli LG; Moridi N; Wang W; Helttunen K; Neuburger M; Vaknin D; Meier W; Shahgaldian P
    Chem Commun (Camb); 2014 Apr; 50(30):3938-40. PubMed ID: 24599407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxylate bioisosteres of gabapentin.
    Burgos-Lepley CE; Thompson LR; Kneen CO; Osborne SA; Bryans JS; Capiris T; Suman-Chauhan N; Dooley DJ; Donovan CM; Field MJ; Vartanian MG; Kinsora JJ; Lotarski SM; El-Kattan A; Walters K; Cherukury M; Taylor CP; Wustrow DJ; Schwarz JB
    Bioorg Med Chem Lett; 2006 May; 16(9):2333-6. PubMed ID: 15946842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of gabapentin in extemporaneously compounded oral suspensions.
    Friciu M; Roullin VG; Leclair G
    PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular structure, electronic properties, NLO, NBO analysis and spectroscopic characterization of Gabapentin with experimental (FT-IR and FT-Raman) techniques and quantum chemical calculations.
    Sinha L; Karabacak M; Narayan V; Cinar M; Prasad O
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 109():298-307. PubMed ID: 23545435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
    Rao MR; Bhingole RC
    Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystalline polymorphism and molecular structure of sodium pravastatin.
    Martín-Islan AP; Cruzado MC; Asensio R; Sainz-Díaz CI
    J Phys Chem B; 2006 Dec; 110(51):26148-59. PubMed ID: 17181270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro investigation into conformational aspects of gabapentin.
    Bryans JS; Horwell DC; Ratcliffe GS; Receveur JM; Rubin JR
    Bioorg Med Chem; 1999 May; 7(5):715-21. PubMed ID: 10400324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of gabapentin into HII mesophases.
    Achrai B; Libster D; Aserin A; Garti N
    J Phys Chem B; 2011 Feb; 115(5):825-35. PubMed ID: 21182317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, synthesis, isolation and characterization of formulation related impurity of Gabapentin.
    Reddy RB; More KR; Jha MS; Sharma B; Magar L
    J Pharm Biomed Anal; 2016 Sep; 129():509-513. PubMed ID: 27497652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic model for solid-state degradation of gabapentin.
    Zong Z; Qiu J; Tinmanee R; Kirsch LE
    J Pharm Sci; 2012 Jun; 101(6):2123-33. PubMed ID: 22419014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylate bioisosteres of pregabalin.
    Schwarz JB; Colbry NL; Zhu Z; Nichelson B; Barta NS; Lin K; Hudack RA; Gibbons SE; Galatsis P; DeOrazio RJ; Manning DD; Vartanian MG; Kinsora JJ; Lotarski SM; Li Z; Dickerson MR; El-Kattan A; Thorpe AJ; Donevan SD; Taylor CP; Wustrow DJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3559-63. PubMed ID: 16621528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.